Banner for leaf pages 2

Donepezil (Aricept)

Also known as Aricept


Donepezil, marketed under the trade name Aricept by its developer Eisai and partner Pfizer, is a centrally acting reversible acetylcholinesterase inhibitor. Its main therapeutic use is in the palliative treatment of mild to moderate Alzheimer's disease. Common side effects include gastrointestinal upset. It has an oral bioavailability of 100% and easily crosses the blood–brain barrier. Because it has a half-life of about 70 hours, it can be taken once a day.

Source: Wikipedia

Estimated Total Cost: $209.52 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed donepezil to treat delirium, alzheimer disease, disturbance of memory, and dementia.

What side effects are related?

Patients taking donepezil most commonly experience side effects like insomnia, diarrhea, and nausea.

Ajax-loader Loading...